Menu
Currency
GWAS Study

Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descent.

Alblooshi H, Al Safar H, El Kashef A et al.

32005204 PubMed ID
GWAS Study Type
452 Participants
33 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AH
Alblooshi H
AS
Al Safar H
EK
El Kashef A
AG
Al Ghaferi H
SM
Shawky M
HG
Hulse GK
TG
Tay GK
Chapter II

Abstract

Summary of the research findings

Genome Wide Association Studies (GWAS) have been conducted to identify genes and pathways involved in development of opioid use disorder. This study extends the first GWAS of substance use disorder (SUD) patients from the United Arab Emirates (UAE) by stratifying the study group based on opioid use, which is the most common substance of use in this cohort.

199 Arabian ancestry cases, 253 Arabian ancestry controls

Chapter III

Study Statistics

Key metrics and study information

452
Total Participants
GWAS
Study Type
No
Replicated
Greater Middle Eastern (Middle Eastern, North African or Persian)
Ancestry
United Arab Emirates
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.